DayZero Mesenchymal Stem Cells by ZEO ScientifiX

Umbilical cord Wharton's Jelly derived mesenchymal stem cells processed in an FDA-registered, ISO7, cGMP-compliant facility ethically sourced and rigorously tested for orthopedic, pain, and wound care applications.

Call 810-588-9612

Introduction

DayZero Stem Cells are mesenchymal stem cells (MSCs) derived from umbilical cord tissue, developed to support a wide range of regenerative and therapeutic applications. Manufactured in FDA-compliant facilities, DayZero products undergo rigorous testing for safety and efficacy, ensuring clinics receive a reliable and consistent stem cell solution for their practice.

Medical spas, orthopedic clinics, and regenerative medicine practices use DayZero Stem Cells to perform treatments such as orthopedic repair, pain management, and wound healing. The product's ready-to-use packaging and multiple dosage formats allow providers to customize treatment protocols based on each patient's condition and therapeutic goals.

Because DayZero Stem Cells come fully tested and certified with complete documentation, clinics can integrate them into their treatment offerings with confidence. This reduces the complexity often associated with biologic products and allows practices to focus on delivering effective regenerative care to their patients.

Key Benefits

  • Ethically sourced mesenchymal stem cells derived from umbilical cord tissue
  • Manufactured in FDA-compliant facilities with rigorous safety and efficacy testing
  • Available in multiple dosage formats to support various treatment protocols
  • Ready-to-use packaging with full documentation and certification for clinical confidence
  • Trusted by regenerative medicine professionals for consistent therapeutic performance

Treatment Applications

Clinics commonly use DayZero Stem Cells for:

  • Orthopedic treatments and joint repair
  • Pain management and inflammation reduction
  • Wound care and tissue healing
  • Regenerative therapy support
  • Soft tissue repair and recovery
  • Chronic condition management

By offering a fully tested and certified stem cell solution, practices can address a wide range of patient regenerative needs using DayZero as part of their therapeutic protocol.

Why Clinics Choose DayZero

Modern regenerative medicine practices require biologic solutions that are safe, effective, and operationally practical. DayZero Stem Cells were developed with this in mind, providing clinics with a highly tested, ethically sourced MSC product that comes with full documentation and safety assurance for seamless clinical integration.

For practices looking to expand their regenerative treatment offerings, DayZero's multiple dosage formats and ready-to-use packaging make it easy to incorporate stem cell therapy into existing workflows. This allows clinics to deliver advanced regenerative care while maintaining efficiency and compliance with regulatory standards.

Frequently Asked Questions

What are DayZero Stem Cells used for?
DayZero Stem Cells are mesenchymal stem cells used to support orthopedic treatments, pain management, wound care, and a variety of regenerative therapy applications.

Are DayZero Stem Cells suitable for medical spas and clinics?
Yes. DayZero Stem Cells are commonly used by medical spas, orthopedic clinics, and regenerative medicine practices looking for a reliable, fully tested stem cell solution with complete documentation.

How are DayZero Stem Cells stored?
DayZero Stem Cells are stored in liquid nitrogen to maintain cell viability and product integrity until they are ready for clinical use.

Are DayZero Stem Cells ethically sourced?
Yes. DayZero Stem Cells are derived from umbilical cord tissue and are ethically sourced, with manufacturing conducted in FDA-compliant facilities under strict quality control standards.

What types of patients can benefit from DayZero Stem Cells?
Patients seeking support for orthopedic conditions, chronic pain, wound healing, tissue repair, or overall regenerative therapy may benefit from treatments using DayZero Stem Cells.

Prepare for the Next Generation Patient